@article{40b453b3a151419e97a584ec07c87669,
title = "Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication",
author = "Hideki Mori and Juntaro Matsuzaki and Hidekazu Suzuki",
note = "Funding Information: During the last 2 years, H.S. received scholarship funds from Astellas Pharm, Inc., Astra-Zeneca K.K., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Zeria Pharmaceutical Co., Ltd., joint research fund from Tosoh Corporation and service honoraria from Astellas Pharma, Inc., Astra-Zeneca K.K., EA Pharma Co., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Tsumura Co. and Zeria Pharmaceutical Co., Ltd.",
year = "2022",
doi = "10.1080/07853890.2022.2053570",
language = "English",
volume = "54",
pages = "856--857",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "1",
}